109 related articles for article (PubMed ID: 7998397)
1. [The interferon reaction of the leukocytes and the natural killer activity in patients with acute viral hepatitis B undergoing interferon treatment].
Golban TD; Cheshik SG; Kuznetsov VP; Beliaev DL; Grishchenko SV; Morgunov KM; Babaiants AA; Polikushina OE; Antonenko SM
Vopr Virusol; 1994; 39(4):177-9. PubMed ID: 7998397
[TBL] [Abstract][Full Text] [Related]
2. [The effect of recombinant alfa-2 interferon (reaferon) on the functional activity of natural killers in acute viral hepatitis B].
Petrovskaia IA; Kushko LIa; Fedorchenko SV; Vovk AD; Listopad NK; Antoniak SN; Drannik GN
Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):56-7. PubMed ID: 8553758
[No Abstract] [Full Text] [Related]
3. [Changes in the activity of the natural killers under the influence of genetically engineered alpha 2-interferon in patients with viral hepatitis B].
Malinovskaia VV; Murzabaeva RT; Bragina GS
Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):97-101. PubMed ID: 2201157
[TBL] [Abstract][Full Text] [Related]
4. [Leukinferon in the treatment of patients with acute viral hepatitis b].
Golban TD; Cheshin SG; Kuznetsov VP; Farber NA; Beliaev DL; Kirzhner LS; Babaiants AA; Vasina VI
Klin Med (Mosk); 1994; 72(3):27-9. PubMed ID: 7990347
[TBL] [Abstract][Full Text] [Related]
5. [Approaches to perfection of Reaferon therapy in hepatitis B].
Korochkina OV
Klin Med (Mosk); 1996; 74(4):22-3. PubMed ID: 8999144
[No Abstract] [Full Text] [Related]
6. [Effectiveness of using recombinant interferon alfa2 (reaferon) combined with antioxidants in children with acute hepatitis B].
Reĭzis AR; Malinovskaia VV; Shekhade S; Drondina AK; Nikitina TS; Markarian AS; Nazarenko IV; Mikhaĭlov MI
Pediatriia; 1992; (1):60-4. PubMed ID: 1614804
[TBL] [Abstract][Full Text] [Related]
7. Natural killer activity in patients with acute viral hepatitis.
Chemello L; Mondelli M; Bortolotti F; Schiavon E; Pontisso P; Alberti A; Rondanelli EG; Realdi G
Clin Exp Immunol; 1986 Apr; 64(1):59-64. PubMed ID: 3089650
[TBL] [Abstract][Full Text] [Related]
8. [Changes in the interferon status of patients with viral hepatitis B when genetically engineered alpha 2-interferon is used].
Pokrovskiĭ VI; Malinovskaia VV; Murzabaeva RT; Vasil'eva VI; Asratian AA
Vopr Virusol; 1990; 35(2):135-8. PubMed ID: 2117831
[TBL] [Abstract][Full Text] [Related]
9. [The efficacy of recombinant alfa-2 interferon in viral hepatitis B].
Frolov AF; Vovk AD; Diadiun ST; Antonenko SV; Petrovskaia IA; Fedorchenko SV; Kushko LIa; Antoniak SN
Vrach Delo; 1990 Sep; (9):105-8. PubMed ID: 1704663
[No Abstract] [Full Text] [Related]
10. [The use of leukinferon by electrophoresis in children with chronic hepatitis].
Uchaĭkin VF; Kuznetsov VP; Cherednichenko TV; Sokolova HV; Syr'eva TN; Chaplygina GV; Konev VA; Iusuf-Zade AA
Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):116-7. PubMed ID: 8079531
[No Abstract] [Full Text] [Related]
11. [Effect of interferon on clinico-laboratory indicators in patients with acute viral hepatitis B].
Pokrovskiĭ VI; Zmyzgova AV; Matveeva SM; Saltykov VP; Soibnazarov ISh
Ter Arkh; 1986; 58(10):29-32. PubMed ID: 3798344
[TBL] [Abstract][Full Text] [Related]
12. [Use of reaferon and antioxidants in children with chronic hepatitis].
Frolov VM; Peresadin NA; Sidorova VS; Germanov VT; Pustovoĭ IuG
Pediatriia; 1992; (4-6):60-2. PubMed ID: 1408577
[No Abstract] [Full Text] [Related]
13. [Interactions of interferon with other immunomodulators in the regulation of human natural killer cell activity].
Cheknev SB; Latysheva OL; Denisov LA; Ershov FI
Biull Eksp Biol Med; 1992 Feb; 113(2):179-82. PubMed ID: 1377045
[TBL] [Abstract][Full Text] [Related]
14. [The natural killer activity and indices of the interferon status of patients with recurrent genital herpes being treated with ridostin].
Cheknev SB; Mikovskaia OI; Meshkova EN; Khaldin AA; Samgin MA; Malinovskaia VV
Vopr Virusol; 1994; 39(3):125-8. PubMed ID: 8091753
[TBL] [Abstract][Full Text] [Related]
15. [The successful treatment of chronic active hepatitis due to hepatitis C viral infection with alpha-interferon and a cytokine complex (a clinical case)].
Karpov VV; Krel' PE
Ter Arkh; 1995; 67(5):84-5. PubMed ID: 7638792
[No Abstract] [Full Text] [Related]
16. [The treatment of different forms of B and delta hepatitis with interferon preparations].
Botsvadze ESh; Kuznetsov VP; Aleksishvili MM; Gogichaĭshvili ShSh
Ter Arkh; 1991; 63(11):61-3. PubMed ID: 1810067
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic antiradiation properties of leukinferon].
Ivanov AA; Kuznetsov VP; Ulanova AM; Stavrakova NM; Kuz'mina TD; Leonenko IV; Gutsenko KK; Shal'nova GA; Beliaev DL; Babaiants AA
Radiats Biol Radioecol; 1998; 38(1):62-70. PubMed ID: 9606407
[TBL] [Abstract][Full Text] [Related]
18. [Immunomodulating properties of leukinferon].
Iushchuk ND; Zmyzgova AV; Tugutova IV; Kuznetsov VP; Babaiants AA; Novikova TA; Eremina OF; Mesniankin AP; Lebedev VV; V'iushina MA
Sov Med; 1990; (7):11-4. PubMed ID: 2251550
[TBL] [Abstract][Full Text] [Related]
19. [Natural killer activity in influenza patients].
Savitskiĭ GI; Grishchenko SV; Krylov VF; Kolobukhina LV; Kniazeva LD
Vopr Virusol; 1988; 33(3):290-2. PubMed ID: 3176429
[TBL] [Abstract][Full Text] [Related]
20. [The use of reaferon in treating patients with protracted viral hepatitis].
Kokoreva LN; Zmyzgova AV; Nazarenko IV
Ter Arkh; 1994; 66(2):21-4. PubMed ID: 8160137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
